Avenue Therapeutics, Inc. (ATXI) stock remained unchanged at $1.36 a share on NASDAQ. The stock opened at $1.36, fluctuating between $1.31 to $1.39 during the session.
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.
Employees | 3 |
Beta | -0.18 |
Sales or Revenue | $0.00 |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Avenue Therapeutics, Inc. (NASDAQ: ATXI) stock price is $1.36 in the last trading session. During the trading session, ATXI stock reached the peak price of $1.39 while $1.31 was the lowest point it dropped to. The percentage change in ATXI stock occurred in the recent session was 0% while the dollar amount for the price change in ATXI stock was -.
The NASDAQ listed ATXI is part of Biotechnology industry that operates in the broader Healthcare sector. Avenue Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Xiaoqin Lu M.D.
Consultant
Dr. Alexandra MacLean M.D.
Chief Executive Officer & Director
Dr. Scott A. Reines M.D., Ph.D.
Interim Chief Medical Officer
Srinivas Subramanian
Executive Vice President
Mr. Srinivas Subramanian
Executive Vice President of Advanced Technology Solutions
ATXI's closing price is 11.47% higher than its 52-week low of $1.22 where as its distance from 52-week high of $15.00 is -90.93%.
Number of ATXI employees currently stands at 3.
Official Website of ATXI is: https://www.avenuetx.com
ATXI could be contacted at phone 781 652 4500 and can also be accessed through its website. ATXI operates from 1140 Avenue of the America, New York, NY 10036, United States.
ATXI stock volume for the day was 47.38K shares. The average number of ATXI shares traded daily for last 3 months was 395.06K.
The market value of ATXI currently stands at $2.79M with its latest stock price at $1.36 and 2.05M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com